Clinical Trials Fund: notice of upcoming funding opportunities
28 April 2022
CIHR is pleased to provide this pre-announcement of the Clinical Trials Fund (CTF) in order to allow the research community time to prepare and respond to what will be an expedited process. This $250 million funding opportunity over 3 years stems from 2021 Federal Budget announcements and in the first phase, is an integral component of Canada’s Biomanufacturing and Life Sciences Strategy. In support of this, the CTF will provide funding through 3 specific vehicles: platforms with the development of a pan-Canadian Clinical Trials Consortium; people with the funding of training platforms; and, projects through the funding of a broad spectrum of clinical trial initiatives.
While these funding opportunities are yet to be finalized, CIHR is providing preliminary information at this time to allow the community to prepare. To ensure that you are receiving timely updates regarding CIHR funding opportunities and other CIHR news, you are encouraged to visit the CIHR website and subscribe to receive the CIHR Access Newsletter.
Source: (CIRHR, 2022)
To read the full notice:
